In This Article:
Beyond Air (NASDAQ:XAIR) Third Quarter 2025 Results
Key Financial Results
-
Revenue: US$1.07m (up 174% from 3Q 2024).
-
Net loss: US$13.0m (loss narrowed by 20% from 3Q 2024).
-
US$0.15 loss per share (improved from US$0.50 loss in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Beyond Air Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 15%. Earnings per share (EPS) also surpassed analyst estimates by 6.3%.
Looking ahead, revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are up 4.9% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 6 warning signs for Beyond Air you should be aware of, and 2 of them are potentially serious.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.